Harvard Bioscience (HBIO) Net Margin Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 124.00 |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -456.00 |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -197.00 |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -303.00 |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 41.00 |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 5.00 |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -1,595.00 |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 102.00 |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | -164.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -164.00 |
| Mar 31, 2026 | 21,448.00 |
| Dec 31, 2025 | -1,334.00 |
| Sep 30, 2025 | 1,583.00 |
| Jun 30, 2025 | 150.00 |
| Mar 31, 2025 | -21,183.00 |
| Dec 31, 2024 | 312.00 |
| Sep 30, 2024 | -1,692.00 |
| Jun 30, 2024 | -927.00 |
| Mar 31, 2024 | -2,117.00 |
| Dec 31, 2023 | 421.00 |
| Sep 30, 2023 | 776.00 |
| Jun 30, 2023 | -1,174.00 |
| Mar 31, 2023 | 2,606.00 |
| Dec 31, 2022 | -930.00 |
| Sep 30, 2022 | -1,207.00 |
| Jun 30, 2022 | 982.00 |
| Mar 31, 2022 | -2,156.00 |
| Dec 31, 2021 | 573.00 |
| Sep 30, 2021 | 407.00 |